| 461 |
3EJY |
CD_A |
3EJY Fab |
H(+)/Cl(-) exchange transporter clcA |
Escherichia coli, Mus musculus |
XRD |
3.2 | 10.1085/jgp.200810112 |
| 462 |
3EJY |
EF_B |
3EJY Fab |
H(+)/Cl(-) exchange transporter clcA |
Escherichia coli, Mus musculus |
XRD |
3.2 | 10.1085/jgp.200810112 |
| 463 |
3EJZ |
CD_A |
3EJZ Fab |
H(+)/Cl(-) exchange transporter clcA |
Escherichia coli, Mus musculus |
XRD |
2.9 | 10.1085/jgp.200810112 |
| 464 |
3EJZ |
EF_B |
3EJZ Fab |
H(+)/Cl(-) exchange transporter clcA |
Escherichia coli, Mus musculus |
XRD |
2.9 | 10.1085/jgp.200810112 |
| 465 |
3EO1 |
BA_C |
GC-1008 Fab |
Transforming growth factor beta-3 |
Mus musculus, Homo sapiens |
XRD |
3.1 | 10.1073/pnas.0807200106 |
| 466 |
3EO1 |
ED_F |
GC-1008 Fab |
Transforming growth factor beta-3 |
Mus musculus, Homo sapiens |
XRD |
3.1 | 10.1073/pnas.0807200106 |
| 467 |
3EO1 |
KJ_L |
GC-1008 Fab |
Transforming growth factor beta-3 |
Mus musculus, Homo sapiens |
XRD |
3.1 | 10.1073/pnas.0807200106 |
| 468 |
3EO1 |
HG_I |
GC-1008 Fab |
Transforming growth factor beta-3 |
Mus musculus, Homo sapiens |
XRD |
3.1 | 10.1073/pnas.0807200106 |
| 469 |
3EOA |
HL_I |
Efalizumab Fab |
Integrin alpha-L |
Homo sapiens |
XRD |
2.8 | 10.1073/pnas.0810844106 |
| 470 |
3EOA |
BA_J |
Efalizumab Fab |
Integrin alpha-L |
Homo sapiens |
XRD |
2.8 | 10.1073/pnas.0810844106 |
| 471 |
3EOB |
HL_I |
Efalizumab Fab |
Integrin alpha-L |
Homo sapiens |
XRD |
3.6 | 10.1073/pnas.0810844106 |
| 472 |
3EOB |
BA_J |
Efalizumab Fab |
Integrin alpha-L |
Homo sapiens |
XRD |
3.6 | 10.1073/pnas.0810844106 |
| 473 |
3ETB |
F_J |
M18 scFv |
anthrax protective antigen domain 4 |
Mus musculus, Bacillus anthracis |
XRD |
3.8 | 10.1016/j.jmb.2009.02.003 |
| 474 |
3ETB |
G_K |
M18 scFv |
anthrax protective antigen domain 4 |
Mus musculus, Bacillus anthracis |
XRD |
3.8 | 10.1016/j.jmb.2009.02.003 |
| 475 |
3ETB |
H_L |
M18 scFv |
anthrax protective antigen domain 4 |
Mus musculus, Bacillus anthracis |
XRD |
3.8 | 10.1016/j.jmb.2009.02.003 |
| 476 |
3ETB |
I_M |
M18 scFv |
anthrax protective antigen domain 4 |
Mus musculus, Bacillus anthracis |
XRD |
3.8 | 10.1016/j.jmb.2009.02.003 |
| 477 |
3EZJ |
B_A |
NBGSPD_7 Nanobody |
General secretion pathway protein GspD |
Escherichia coli ETEC H10407, Lama glama |
XRD |
2.8 | 10.1016/j.str.2008.11.011 |
| 478 |
3EZJ |
D_C |
NBGSPD_7 Nanobody |
General secretion pathway protein GspD |
Escherichia coli ETEC H10407, Lama glama |
XRD |
2.8 | 10.1016/j.str.2008.11.011 |
| 479 |
3EZJ |
F_E |
NBGSPD_7 Nanobody |
General secretion pathway protein GspD |
Escherichia coli ETEC H10407, Lama glama |
XRD |
2.8 | 10.1016/j.str.2008.11.011 |
| 480 |
3EZJ |
H_G |
NBGSPD_7 Nanobody |
General secretion pathway protein GspD |
Escherichia coli ETEC H10407, Lama glama |
XRD |
2.8 | 10.1016/j.str.2008.11.011 |